Profilo
Yoram Halevy served as the Chief Executive Officer of Ofakim Hi-Tech Ventures Ltd.
from 1999 to 2012.
He also worked as a Director at Polyrizon Ltd.
Mr. Halevy received an undergraduate degree from Tel-Aviv University and an MBA from The Hebrew University of Jerusalem.
Precedenti posizioni note di Yoram Halevy
| Società | Posizione | Fine |
|---|---|---|
Ofakim Hi-Tech Ventures Ltd.
 Ofakim Hi-Tech Ventures Ltd. Investment ManagersFinance Ofakim Hi-Tech Ventures Ltd. (Ofakim Hi-Tech Ventures) is a venture capital subsidiary of Capital Point Ltd. founded in 1991. The firm is headquartered in Ofakim, Israel. | Amministratore Delegato | 30/05/2012 |
Polyrizon Ltd.
 Polyrizon Ltd. BiotechnologyHealth Technology Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel. | Direttore/Membro del Consiglio | - |
Formazione di Yoram Halevy
| The Hebrew University of Jerusalem | Masters Business Admin |
| Tel-Aviv University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Ofakim Hi-Tech Ventures Ltd.
Ofakim Hi-Tech Ventures Ltd. Investment ManagersFinance Ofakim Hi-Tech Ventures Ltd. (Ofakim Hi-Tech Ventures) is a venture capital subsidiary of Capital Point Ltd. founded in 1991. The firm is headquartered in Ofakim, Israel. | Finance |
Polyrizon Ltd.
Polyrizon Ltd. BiotechnologyHealth Technology Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel. | Health Technology |
- Borsa valori
- Insiders
- Yoram Halevy
